Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

.gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Clinicalinfo.HIV.gov logo.
In affiliation with HIV.gov
Main navigation
  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Resources
  • Contact Us
  • English
  • Español (Spanish)

Language:

  • English
  • Español

clinicalinfo.hiv.gov

Offering Information on HIV/AIDS Treatment, Prevention, and Research

Clinical Guidelines

Federally approved medical practice guidelines for HIV/AIDS.
Guidelines 

Drug Database

Information on FDA-approved HIV/AIDS and opportunistic infection drugs and investigational HIV/AIDS drugs. Drugs 

Glossary

Medical dictionary of HIV-related terms.
Glossary 

Resources

HIV-related resources from the National Institutes of Health.
Resources 

What to Start: Nucleoside Reverse Transcriptase Inhibitor Options

  • Read more about What to Start: Nucleoside Reverse Transcriptase Inhibitor Options

What to Start: Integrase Strand Transfer Inhibitor Regimens

  • Read more about What to Start: Integrase Strand Transfer Inhibitor Regimens

What to Start: Non-Nucleoside Reverse Transcriptase Inhibitor Regimens

  • Read more about What to Start: Non-Nucleoside Reverse Transcriptase Inhibitor Regimens

What to Start: Initial Antiretroviral Therapy Based on Specific Clinical Scenarios

  • Read more about What to Start: Initial Antiretroviral Therapy Based on Specific Clinical Scenarios

What to Start: Other Antiretroviral Regimens When Abacavir and Tenofovir Cannot Be Used or Are Not Optimal

  • Read more about What to Start: Other Antiretroviral Regimens When Abacavir and Tenofovir Cannot Be Used or Are Not Optimal

What to Start: Advantages and Disadvantages of Antiretroviral Components of Initial Antiretroviral Therapy

  • Read more about What to Start: Advantages and Disadvantages of Antiretroviral Components of Initial Antiretroviral Therapy

What to Start: Protease Inhibitor–Based Regimens

  • Read more about What to Start: Protease Inhibitor–Based Regimens

What to Start: Initial Combination Antiretroviral Regimens

  • Read more about What to Start: Initial Combination Antiretroviral Regimens

Antiretroviral Pregnancy Registry

  • Read more about Antiretroviral Pregnancy Registry

Archived Drugs

  • Read more about Archived Drugs

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Current page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »

CONNECT WITH US

Footer menu

  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Resources
  • Contact Us
  • Sponsors
  • Nondiscrimination Notice
  • Accessibility
  • Disclaimers
  • Sitemap
  • Privacy Policy
  • HHS Vulnerability Disclosure

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Freedom of Information Act

Provided in collaboration with NIH’s Office of AIDS Research.